Citi Reiterates Neutral Rating on Arrowhead Pharma (ARWR)
Go back to Citi Reiterates Neutral Rating on Arrowhead Pharma (ARWR)| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 85.88 +0.51 (0.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.37 | 52 Week High | $8.22 | |||
| Open | $85.18 | 52 Week Low | $3.07 | |||
| Day High | $85.88 | P/E | N/A | |||
| Day Low | $83.46 | EPS | $-1.30 | |||
| Volume | 839,768 | |||||
